This page is part of the FHIR Specification (v5.0.0-ballot: FHIR R5 Ballot Preview). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Device, Encounter, Patient, Practitioner, RelatedPerson |
Raw JSON (canonical form + also see JSON Format Specification)
Intravenous Chemotherapy (Inpatient order) - Alemtuzumab - completed
{ "resourceType": "MedicationAdministration", "id": "medadmin0304", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationAdministration</b><a name=\"medadmin0304\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationAdministration "medadmin0304" </p></div><p><b>status</b>: completed</p><h3>Medications</h3><table class=\"grid\"><tr><td>-</td><td><b>Reference</b></td></tr><tr><td>*</td><td><a name=\"med0303\"> </a><blockquote><p/><p><a name=\"med0303\"> </a></p><p><b>code</b>: Alemtuzumab 10mg/ml (Lemtrada) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#1594660)</span></p></blockquote></td></tr></table><p><b>subject</b>: <a href=\"patient-example-a.html\">Patient/pat1: Donald Duck</a> "Donald DUCK"</p><p><b>encounter</b>: <a href=\"encounter-example-f001-heart.html\">Encounter/f001: encounter who leads to this prescription</a></p><p><b>occurence</b>: 2015-01-15T04:30:00+01:00 --> 2015-01-15T14:30:00+01:00</p><h3>Performers</h3><table class=\"grid\"><tr><td>-</td><td><b>Actor</b></td></tr><tr><td>*</td><td><a href=\"practitioner-example-f007-sh.html\">Practitioner/f007: Patrick Pump</a> "Simone HEPS"</td></tr></table><h3>Reasons</h3><table class=\"grid\"><tr><td>-</td><td><b>Reference</b></td></tr><tr><td>*</td><td><a href=\"condition-example-f202-malignancy.html\">Condition/f202</a></td></tr></table><p><b>request</b>: <a href=\"medicationrequest0319.html\">MedicationRequest/medrx0319</a></p><h3>Dosages</h3><table class=\"grid\"><tr><td>-</td><td><b>Text</b></td><td><b>Route</b></td><td><b>Method</b></td><td><b>Dose</b></td></tr><tr><td>*</td><td>Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk</td><td>Intravenous route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#47625008)</span></td><td>Inject - dosing instruction imperative (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#422145002)</span></td><td>3 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span></td></tr></table></div>" }, "contained": [ { "resourceType": "Medication", "id": "med0303", "code": { "coding": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "code": "1594660", "display": "Alemtuzumab 10mg/ml (Lemtrada)" } ] } } ], "status": "completed", "medication": { "reference": { "reference": "#med0303" } }, "subject": { "reference": "Patient/pat1", "display": "Donald Duck" }, "encounter": { "reference": "Encounter/f001", "display": "encounter who leads to this prescription" }, "occurencePeriod": { "start": "2015-01-15T04:30:00+01:00", "end": "2015-01-15T14:30:00+01:00" }, "performer": [ { "actor": { "reference": "Practitioner/f007", "display": "Patrick Pump" } } ], "reason": [ { "reference": { "reference": "Condition/f202" } } ], "request": { "reference": "MedicationRequest/medrx0319" }, "dosage": { "text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk", "route": { "coding": [ { "system": "http://snomed.info/sct", "code": "47625008", "display": "Intravenous route (qualifier value)" } ] }, "method": { "coding": [ { "system": "http://snomed.info/sct", "code": "422145002", "display": "Inject - dosing instruction imperative (qualifier value)" } ] }, "dose": { "value": 3, "unit": "mg", "system": "http://unitsofmeasure.org", "code": "mg" } } }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.